Acute hepatitis E during biotherapy

Joint Bone Spine. 2013 Jan;80(1):91-2. doi: 10.1016/j.jbspin.2012.08.001. Epub 2012 Sep 19.

Abstract

Hepatitis E is a rare and usually asymptomatic infection. However, its incidence is rising in France, and it can cause severe or chronic manifestations in immunocompromised patients. Here, we report a case of hepatitis E in a patient with rheumatoid arthritis who had immunosuppression due to treatment with a biological agent.

Publication types

  • Case Reports

MeSH terms

  • Abatacept
  • Aged
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Hepatitis E / chemically induced
  • Hepatitis E / etiology
  • Hepatitis E / therapy*
  • Humans
  • Immunocompromised Host
  • Immunoconjugates / adverse effects*
  • Immunoconjugates / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use

Substances

  • Immunoconjugates
  • Immunosuppressive Agents
  • Abatacept